Accueil>>Signaling Pathways>> Proteases>> Endogenous Metabolite>>Menaquinone-4 (Vitamin K2)

Menaquinone-4 (Vitamin K2) (Synonyms: MK-4, Vitamin K2(20))

Catalog No.GC30258

La ménaquinone-4 (vitamine K2) est une vitamine K, utilisée comme agent hémostatique, et également comme traitement d'appoint pour la douleur de l'ostéoporose.

Products are for research use only. Not for human use. We do not sell to patients.

Menaquinone-4 (Vitamin K2) Chemical Structure

Cas No.: 863-61-6

Taille Prix Stock Qté
10mM (in 1mL DMSO)
39,00 $US
En stock
100mg
35,00 $US
En stock
250mg
56,00 $US
En stock
1g
162,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Menaquinone-4 is a vitamin K, used as a hemostatic agent, and also a adjunctive therapy for the pain of osteoporosis.

Menaquinone-4 (MK-4, 0, 1, 5, 10 μM) increases the ALP activity in Caco-2 cells. Menaquinone-4 (1 μM) significantly increases intensities of hSI expression[1].

Menaquinone-4 (K2, 0.2 g/kg diet) in HF-K2 group produces epididymal fat in C57BL/6J mice, and also increases the bone density of mice[2].

[1]. Noda S, et al. Menaquinone-4 (vitamin K2) up-regulates expression of human intestinal alkaline phosphatase in Caco-2 cells. Nutr Res. 2016 Nov;36(11):1269-1276. [2]. Kim M, et al. Vitamin K1 (phylloquinone) and K2 (menaquinone-4) supplementation improves bone formation in a high-fat diet-induced obese mice. J Clin Biochem Nutr. 2013 Sep;53(2):108-13.

Avis

Review for Menaquinone-4 (Vitamin K2)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Menaquinone-4 (Vitamin K2)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.